Jade Biosciences JBIO
NASDAQ JBIO
$14.18 -0.17 (-1.18%)
At close: Sep 29, 2026 · 4:00 PM EDT

Jade Biosciences (JBIO) Non-Current Assets (2020 - 2026)

Updated

Jade Biosciences (JBIO) recorded Non-Current Assets of $862,000 in Q2 2026, down 12.4% from $984,000 a year earlier and down 5.9% from the prior quarter.

Analysis

Jade Biosciences (JBIO) Non-Current Assets (2020 - 2026) Analysis & Trends

At the end of FY2025, Jade Biosciences reported Non-Current Assets of $965,000, down 69.3% from FY2024.

  • Annual Non-Current Assets has declined for three straight years, though with a five-year compound annual growth rate of 90.0% (FY2020 to FY2025).
  • Across earlier years, Non-Current Assets came in at $3.15 million in FY2024 (-1.3%), $3.19 million in FY2023 (-16.3%), $3.81 million in FY2022 (+269.4%) and $1.03 million in FY2021.
  • The Q2 2026 figure is the lowest quarterly Non-Current Assets since Q1 2025.
  • On a year-over-year basis, Non-Current Assets rose in three of the last eight quarters, with growth averaging 52.3%.
  • Peak year-over-year performance for Non-Current Assets in the last five years was growth of 472.5% in Q1 2026, against a decline of 95.5% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $916,000 (Q1 2026), $965,000 (Q4 2025) and $1.09 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Jade Biosciences 912.03 Mn 912.03 Mn - 862,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 862,000.00
Mar 31, 2026 916,000.00
Dec 31, 2025 965,000.00
Sep 30, 2025 1.09 Mn
Jun 30, 2025 984,000.00
Mar 31, 2025 160,000.00
Dec 31, 2024 3.15 Mn
Sep 30, 2024 354,000.00
Jun 30, 2024 934,000.00
Mar 31, 2024 3.58 Mn
Dec 31, 2023 3.19 Mn
Sep 30, 2023 3.27 Mn
Jun 30, 2023 3.29 Mn
Mar 31, 2023 3.82 Mn
Dec 31, 2022 3.81 Mn
Sep 30, 2022 2.50 Mn
Jun 30, 2022 2.24 Mn
Mar 31, 2022 1.11 Mn
Dec 31, 2021 1.03 Mn
Sep 30, 2021 1.02 Mn
API Access

Jade Biosciences Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=JBIO&period=max&api_key=YOUR_API_KEY